Abstract
We present the results of the study of lipid-modulating drugs (pravastatin, atorvastatin, simvastatin, and fibrate gemfibrozil) in complicated coronary heart disease (acute coronary syndrome without ST elevation, chronic heart failure. In acute coronary syndrome statins produced a positive effect on some studied parameters, while in heart failure only the safety of short-term therapy with statins was demonstrated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
N. A. Vaulin and N. A. Gratsianskii, Kardiologiya, 41, No. 11, 4–10 (2001).
N. A. Vaulin, N. A. Gratsianskii, N. N. Slavina, and O. V. Averkov, Ibid., 39, No. 8, 42–52 (1999).
N. A. Vaulin, N. A. Gratsianskii, I. S. Yavelov, and O. V. Averkov, Ibid., 41, No. 5, 4–8 (2001).
E. V. Pokrovskaya, N. A. Vaulin, N. A. Gratsianskii, et al., Ibid., 43, No. 1, 7–18 (2003).
E. V. Pokrovskaya, N. A. Gratsianskii, O. V. Averkov, et al., Ibid., No. 6, pp. 4–13.
E. V. Pokrovskaya, N. A. Gratsianskii, N. A. Vaulin, and A. D. Deev, Ibid., 44, No. 7, 40–45 (2004).
I. N. Smetanina, N. A. Vaulin, and N. A. Gratsianskii, Kardiologiya, 46, No. 5, 44–49 (2006).
I. S. Anand, V. G. Florea, M. A. Kuskowski, et al., Eur. Heart J., 25, Suppl. 1, 245 (2004).
P. O. Bonetti, L. O. Lerman, C. Napoli, A. Lerman, Ibid., 24, No. 3, 225–248 (2003).
J. A. de Lemos, M. A. Blazing, S. D. Wiviott, et al., JAMA, 292, No. 11, 1307–1316 (2004).
H. Fukuta, D. C. Sane, S. Brucks, and W. C. Litte, Circulation, 112, No. 3, 357–363 (2005).
Heart Protection Study Collaborative Group et al., J. Am. Coll. Cardiol., 49, No. 3, 311–319 (2007).
T. B. Horwich, R. MacLellan, and G. C. Fonarow, Ibid., 43, No. 4, 642–648 (2004).
H. Lee, W. Shi, P. Tontonoz, et al., Circ. Res., 87, No. 6, 516–521 (2000).
P. Libby, Circulation, 104, No. 3, 365–372 (2001).
G. Martin, H. Duez, C. Blanquart, et al., J. Clin. Invest., 107, No. 11, 1423–1432 (2001).
S. J. Robins, D. Collins, J. T. Wittes, et al., JAMA, 285, No. 12, 1585–1591 (2001).
G. G. Schwartz, A. G. Olsson, M. D. Ezekowitz, et al., JAMA, 285, No. 13, 1711–1718 (2001).
P. L. Thompson, I. Meredith, J. Amerena, et al. Am. Heart J., 148, No. 1, e2 (2004).
Author information
Authors and Affiliations
Additional information
__________
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Supplement 2, pp. 67–75, April, 2007
Rights and permissions
About this article
Cite this article
Gratsianskii, N.A., Vaulin, N.A. Use of lipid-modulating drugs in complicated course of coronary heart disease. Bull Exp Biol Med 144, 438–446 (2007). https://doi.org/10.1007/s10517-007-0348-8
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10517-007-0348-8